NXTC NextCure, Inc.

Provides biopharmaceutical new immuno oncology products.

$7.06
As of 07/23/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/08/2019
Outstanding shares:  27,609,863
Average volume:  346,666
Market cap:   $197,962,718
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    65343E108
ISIN:        US65343E1082
Sedol:      BJL3CL5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.63
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy